DE69013476D1 - Anwendung von Naphthoxazinen. - Google Patents

Anwendung von Naphthoxazinen.

Info

Publication number
DE69013476D1
DE69013476D1 DE69013476T DE69013476T DE69013476D1 DE 69013476 D1 DE69013476 D1 DE 69013476D1 DE 69013476 T DE69013476 T DE 69013476T DE 69013476 T DE69013476 T DE 69013476T DE 69013476 D1 DE69013476 D1 DE 69013476D1
Authority
DE
Germany
Prior art keywords
naphthoxazines
schaemia
cerebral
stroke
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69013476T
Other languages
English (en)
Other versions
DE69013476T2 (de
Inventor
Joachim Nozulak
Andre Sauter
Jean-Marie Vigouret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928316A external-priority patent/GB8928316D0/en
Priority claimed from DE19904003262 external-priority patent/DE4003262A1/de
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Application granted granted Critical
Publication of DE69013476D1 publication Critical patent/DE69013476D1/de
Publication of DE69013476T2 publication Critical patent/DE69013476T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69013476T 1989-12-14 1990-12-11 Anwendung von Naphthoxazinen. Expired - Fee Related DE69013476T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898928316A GB8928316D0 (en) 1989-12-14 1989-12-14 Improvements in or relating to organic compounds
DE19904003262 DE4003262A1 (de) 1990-02-03 1990-02-03 Neues naphthoxazin, seine herstellung und verwendung

Publications (2)

Publication Number Publication Date
DE69013476D1 true DE69013476D1 (de) 1994-11-24
DE69013476T2 DE69013476T2 (de) 1995-05-04

Family

ID=25889734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69013476T Expired - Fee Related DE69013476T2 (de) 1989-12-14 1990-12-11 Anwendung von Naphthoxazinen.

Country Status (15)

Country Link
US (1) US5190941A (de)
EP (1) EP0433239B1 (de)
JP (1) JPH0825880B2 (de)
KR (1) KR0182276B1 (de)
AT (1) ATE113040T1 (de)
AU (1) AU639512B2 (de)
CA (1) CA2032132A1 (de)
CY (1) CY2065B1 (de)
DE (1) DE69013476T2 (de)
DK (1) DK0433239T3 (de)
ES (1) ES2063328T3 (de)
HK (1) HK1000244A1 (de)
HU (1) HU214591B (de)
IE (1) IE66143B1 (de)
PT (1) PT96178B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000124A1 (en) * 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
HU193979B (en) * 1984-06-12 1987-12-28 Sandoz Ag Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them
EP0233728A1 (de) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CY2065B1 (en) 1998-06-12
ES2063328T3 (es) 1995-01-01
CA2032132A1 (en) 1991-06-15
PT96178B (pt) 1998-04-30
DE69013476T2 (de) 1995-05-04
IE66143B1 (en) 1995-12-13
PT96178A (pt) 1991-09-30
ATE113040T1 (de) 1994-11-15
KR910011261A (ko) 1991-08-07
DK0433239T3 (da) 1995-01-16
HU908017D0 (en) 1991-06-28
JPH03271223A (ja) 1991-12-03
HUT57749A (en) 1991-12-30
KR0182276B1 (ko) 1999-05-01
AU639512B2 (en) 1993-07-29
JPH0825880B2 (ja) 1996-03-13
EP0433239B1 (de) 1994-10-19
HU214591B (hu) 1998-04-28
AU6797590A (en) 1991-06-20
EP0433239A1 (de) 1991-06-19
US5190941A (en) 1993-03-02
HK1000244A1 (en) 1998-02-13
IE904497A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
FI915920A (fi) Serotoninantagonister.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
DE68901958T2 (de) Kontrastmittel mit stabilen, freien radikalen.
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ATE79622T1 (de) 1,4-diazepine.
DE69424009T2 (de) Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst
DK0459256T3 (da) Oxazolidiononer
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE144498T1 (de) Herstellung von substituierten piperidinen
ATE162181T1 (de) Phenylalkan(en)-säuren mit leukotriene b4 antagonistischer wirkung
ATE70274T1 (de) Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69013476T2 (de) Anwendung von Naphthoxazinen.
DE59104132D1 (de) Verwendung von 2-n-Alkyl-1,2-benzisothiazolin-3-onen als technische Mikrobiozide.
DE68911237T2 (de) Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
DE3783070T2 (de) Phenylharnstoffe.
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
DE69131058T2 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
SE8700566D0 (sv) Tetracyclic quinazolinones
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
FI882388A (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
DE3767940D1 (de) Pyranderivate.
SU1783806A1 (ru) 7-(1-гидрокси-1-трифторметил-2,2,2-трифторэтил)- и 5-(1-гидрокси-1-метоксикарбонил-2,2,2-трифторэтил)-8-трибутилоловооксихинолины в качестве фунгицидов против фитофтороза
IT1255474B (it) Derivati 1,4-benzotiazinici ad attivita' calcio antagonista

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8328 Change in the person/name/address of the agent

Free format text: SPOTT WEINMILLER & PARTNER, 80336 MUENCHEN

8339 Ceased/non-payment of the annual fee